Prestigious licensor UNC Lineberger is an NCI-designated Comprehensive Cancer Center with the highest exceptional rating, indicating strong research credibility and potential for high-value collaborations, sponsored research, and large-scale grant opportunities.

Public data resource Launched a public cancer data resource enabling monitoring of new diagnoses, access to care, and health trends, presenting a channel for data licensing, analytics services, and collaborative studies with healthcare providers and policymakers.

Strategic partnerships Existing collaborations with Cherokee Indian Hospital Authority and industry partners (Arovella Therapeutics) suggest openness to sponsored research, joint clinical studies, and sponsored programs that can be expanded to target oncology therapeutics and device trials.

Clinical and translational focus Strength in translating lab discoveries to clinical trials and patient care, offering opportunities for co-development, contract research, and technology transfer with biotech and pharma firms seeking translational expertise.

Diverse research platforms A multidisciplinary tech stack and robust imaging, genomics, and computational capabilities imply potential for managed services, data analytics partnerships, and software tool integrations tailored to oncology research.